[
    [
        {
            "time": "2018-07-16",
            "original_text": "【招商策略】 保险资金权益投资占比止跌回升，重要股东净增持——金融市场流动性与监管动态周报（0716）",
            "features": {
                "keywords": [
                    "保险资金",
                    "权益投资",
                    "止跌回升",
                    "净增持",
                    "流动性",
                    "监管动态"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【招商策略】 保险资金权益投资占比止跌回升，重要股东净增持——金融市场流动性与监管动态周报（0716）",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-07-16",
            "original_text": "晨会精选（2018年7月16日）",
            "features": {
                "keywords": [
                    "晨会精选",
                    "市场分析"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "晨会精选（2018年7月16日）",
                "Correlation": 3,
                "Sentiment": 5,
                "Importance": 4,
                "Impact": 3,
                "Duration": 3,
                "Entity_Density": 2,
                "Market_Scope": 5,
                "Time_Proximity": 3,
                "Headline_Structure": 4,
                "Source_Recency": 2
            }
        },
        {
            "time": "2018-07-16",
            "original_text": "恒瑞医药股票: 长效粒细胞刺激因子获批上市, 重磅品种不断兑现 (2)",
            "features": {
                "keywords": [
                    "恒瑞医药",
                    "长效粒细胞刺激因子",
                    "获批上市",
                    "重磅品种"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "恒瑞医药股票: 长效粒细胞刺激因子获批上市, 重磅品种不断兑现 (2)",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-07-16",
            "original_text": "[强于大市评级] 医药生物行业研究周报：中报行情持续 从“业绩”角度筛选优质标的",
            "features": {
                "keywords": [
                    "医药生物",
                    "中报行情",
                    "业绩",
                    "优质标的"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[强于大市评级] 医药生物行业研究周报：中报行情持续 从“业绩”角度筛选优质标的",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-07-16",
            "original_text": "抢反弹 北上资金持续加仓",
            "features": {
                "keywords": [
                    "北上资金",
                    "加仓",
                    "抢反弹"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "抢反弹 北上资金持续加仓",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-07-16",
            "original_text": "恒瑞医药高昂研发费背后 药神孙飘扬如何应对未来",
            "features": {
                "keywords": [
                    "恒瑞医药",
                    "研发费",
                    "孙飘扬",
                    "应对未来"
                ],
                "sentiment_score": 0.4,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "恒瑞医药高昂研发费背后 药神孙飘扬如何应对未来",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        }
    ]
]